Kohjin Bio Co., Ltd.
Sectors
Pharma & Medical, Power & Energy
Where it builds
Saitama, Nagasaki
Stage
1 planned · 2 building
| Posted | Project | Sector | Location | Investment | Phase |
|---|---|---|---|---|---|
| 2026.08.07 | Kohjin Bio to build cell culture facility at its Sakado headquartersKohjin Bio plans to establish a cell culture facility at its headquarters in Sakado, Saitama, to expand its cell-processing business. The project has a total planned investment of ¥388.084 million, with construction scheduled from June 2025 to November 2026 and capacity expected to increase by approximately 1,000 specimens. | Pharma & Medical | Sakado, Saitama | ¥388.1M | Building |
| 2026.08.07 | Kohjin Bio to build new culture media manufacturing plant in OmuraKohjin Bio plans to establish a new culture media manufacturing plant at its Nagasaki Factory in Omura, Nagasaki. Construction began in July 2025 and completion is scheduled for March 2030; the total planned investment and post-completion capacity have not been disclosed. | Pharma & Medical | Omura, Nagasaki | not disclosed | Building |
| 2026.08.07 | Kohjin Bio to install emergency power equipment at its Saitama headquartersKohjin Bio plans to install emergency power equipment at its headquarters in Sakado, Saitama. The project is scheduled to begin in January 2027 and be completed in June 2027, funded with proceeds from a capital increase. | Power & Energy | Sakado, Saitama | ¥92.1M | Planned |
- Seven Industry Co., Ltd.2 projects · ¥184.9B
- Daiichi Sankyo Europe GmbH3 projects · ¥167.8B
- Daiichi Sankyo4 projects · ¥133B
- Idemitsu Kosan Co., Ltd.3 projects · ¥131.5B
- Sekisui Chemical Co., Ltd.4 projects · ¥96.3B
- Tsumura & Co.5 projects · ¥67.7B
Browse the sector: Pharma & Medical, Power & Energy.